Bronchogen Reconstitution Calculator
Calculate reconstitution volumes, syringe draw amounts, and doses per vial for Bronchogen.
- Concentration
- 25 mcg per unit
- Doses per vial
- 50
100 mcg = 4 units · 0.04 ml
This information is for research only. Not intended for human use.
How to reconstitute Bronchogen
- Use bacteriostatic water (0.9% benzyl alcohol) as the default diluent.
- Add the diluent slowly down the vial wall and roll gently; do not shake.
- Store lyophilized powder at about -20 °C long-term, or 2–8 °C short-term.
- Refrigerate reconstituted solution at 2–8 °C and use within 14–28 days.
- Discard reconstituted solution if particulate or discoloration appears.
Frequently asked questions
Is Bronchogen FDA-approved?+
No. Bronchogen (Ala-Asp-Glu-Leu) is an experimental short tetrapeptide bronchial bioregulator. Available evidence is preclinical: anti-inflammatory and regenerative effects in obstructive lung pathology models, morphofunctional improvements in rat bronchial epithelium, and gene/protein regulation in bronchial epithelium. DNA thermostability and chromatin interaction studies support direct nuclear effects. No human RCT or regulatory approval data are present in the corpus.
Is subcutaneous or intranasal better?+
No comparative human route data exist. Bronchogen (Ala-Asp-Glu-Leu) is distinct from the related tetrapeptide Ala-Glu-Asp-Leu (AEDL). The AEDL tetrapeptide has been formulated with dendrimer nanocontainers; carriers held 14–16 peptide molecules and improved capacity ~8% at lower pH, indicating delivery challenges for free peptide. Community protocols use subcutaneous injection or intranasal spray; oral use is uncommon due to expected gastrointestinal peptide breakdown (community protocol). No human route superiority is established.
What dose should I use at 160 lbs?+
No body-weight-based human dosing data exist. Animal studies used peptide therapy in obstructive lung pathology models, but exact doses are not abstracted. Community practice commonly uses Bronchogen 50–100 mcg/day SC or 500 mcg–1 mg/day intranasal route for 10–20 days (community protocol). This is not a validated human dose.
How long can I take Bronchogen?+
Preclinical studies used repeated dosing for bronchial epithelial effects. No long-term human safety data exist. Community protocols typically use 10–20-day cycles with 3–6 months off, not continuous administration (community protocol).
How does Bronchogen compare to pineal peptide Ala-Glu-Asp-Gly?+
Bronchogen is tissue-specific for bronchial epithelium and lung function. Synthetic bioregulators show tissue-specific effects in organotypic tissue cultures and aging models. The pineal tetrapeptide Ala-Glu-Asp-Gly targets pineal melatonin secretion. Bronchogen should not be assumed interchangeable with other bioregulators.
Can I travel with Bronchogen or does Bronchogen need refrigeration?+
Lyophilized Bronchogen should be stored frozen at approximately -20°C; after reconstitution with bacteriostatic water, keep at 2–8°C and use within 14–28 days (community protocol). Travel with injectable peptides generally requires prescription documentation and adherence to local regulations; no corpus data cover this.
Researching Bronchogen?
Read the full Bronchogen profile for mechanism, protocols, and cited research, or ask ChatPEP directly.